Related Experiment Video
Updated: Aug 30, 2026
Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
Residual triamcinolone acetonide in the macular hole after vitrectomy
Masaru Takeuchi1, Yoshiaki Katagiri, Masahiko Usui
1Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan. takeuchi@tokyo-med.ac.jp
Purpose:
To report a case of vitrectomy using intraocular triamcinolone acetonide (TA), in which TA remained in the macular hole after surgery.
Design:
Observational case report.
Methods:
A 60-year-old Japanese man had a Stage II macular hole in the right eye with best-corrected visual acuity of 20/50. A pars plana vitrectomy using TA was performed. Visual acuity and anatomic results were followed up for a period of 8 weeks.
Results:
On the sixth postoperative day, residual TA deposition was observed in the macular hole. On the 14th postoperative day, no residual TA was found and the macular hole was successfully closed. The best-corrected visual acuity of the right eye improved to 20/15.
Conclusions:
Residual TA in the macular hole after vitrectomy did not interfere with macular hole repair either anatomically or functionally.
